No Photo Available

Last Update

2016-12-01T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Pawel Kalinski?

Dr. Pawel Kalinski

Professor of Bioengineering

University of Pittsburgh

HQ Phone: (412) 624-2100

Email: p***@***.edu

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

University of Pittsburgh

3811 O'Hara Street

Pittsburgh, Pennsylvania 15213

United States

Company Description

We are a theoretical & computational chemistry group at the University of Pittsburgh. We develop and apply electronic structure approaches to help guide discoveries in catalysis, spectroscopy, and materials chemistry. Our research areas include: (1) Dev ... more

Find other employees at this company (34,484)

Background Information

Employment History

Consulting Editor

Journal of Clinical Investigation

Director At Large

Society for Immunotherapy of Cancer

Associate Professor of Surgery

University of Pittsburgh School of Medicine

Affiliations

Planning Committee Member
Translational Research Cancer Centers Consortium

Board Member
atLarge Inc

Core Member
International Society for Biological Therapy of Cancer

Education

M.D.

University of Pittsburgh Melanoma Program

MD

University of Pittsburgh/University of Pittsburgh Cancer Institute

PhD

University of Pittsburgh Cancer Institute

Web References (111 Total References)


Pawel ...

insight.jci.org [cached]

Pawel Kalinski University of Pittsburgh


Pawel Kalinski, a professor ...

tbo.com [cached]

Pawel Kalinski, a professor of surgery at the University of Pittsburgh, sees the value in that. He has done cancer immunotherapy trials, some using a patients own (autologous) tumor cells, others using tumor cells from other donors. The donated cells dont always target the cancer effectively, but the patients own cells are always a match. When we are using autologous tumor cells, we know that we will be able to treat that patient, he said.

He said StoreMyTumor might help him treat patients who are no longer candidates for surgery, or who dont have easily identifiable tumor mass.
Maybe five or 10 years from now, most of the high-risk patients tumors will be banked, one way or another, he said.


Pawel Kalinski, a professor ...

tbo.com [cached]

Pawel Kalinski, a professor of surgery at the University of Pittsburgh, sees the value in that. He has done cancer immunotherapy trials, some using a patients own (autologous) tumor cells, others using tumor cells from other donors. The donated cells dont always target the cancer effectively, but the patients own cells are always a match. When we are using autologous tumor cells, we know that we will be able to treat that patient, he said.

He said StoreMyTumor might help him treat patients who are no longer candidates for surgery, or who dont have easily identifiable tumor mass.
Maybe five or 10 years from now, most of the high-risk patients tumors will be banked, one way or another, he said.


Pawel Kalinski, a professor ...

tbo.com [cached]

Pawel Kalinski, a professor of surgery at the University of Pittsburgh, sees the value in that. He has done cancer immunotherapy trials, some using a patients own (autologous) tumor cells, others using tumor cells from other donors. The donated cells dont always target the cancer effectively, but the patients own cells are always a match. When we are using autologous tumor cells, we know that we will be able to treat that patient, he said.

He said StoreMyTumor might help him treat patients who are no longer candidates for surgery, or who dont have easily identifiable tumor mass.
Maybe five or 10 years from now, most of the high-risk patients tumors will be banked, one way or another, he said.


Pawel Kalinski, a professor ...

tbo.com [cached]

Pawel Kalinski, a professor of surgery at the University of Pittsburgh, sees the value in that. He has done cancer immunotherapy trials, some using a patients own (autologous) tumor cells, others using tumor cells from other donors. The donated cells dont always target the cancer effectively, but the patients own cells are always a match. When we are using autologous tumor cells, we know that we will be able to treat that patient, he said.

He said StoreMyTumor might help him treat patients who are no longer candidates for surgery, or who dont have easily identifiable tumor mass.
Maybe five or 10 years from now, most of the high-risk patients tumors will be banked, one way or another, he said.

Similar Profiles

Other People with this Name

Other people with the name Kalinski

Robert Kalinski
YMCA

Edward Kalinski
AB Italia

Marek Kalinski
Alisa Cohn

Alison Kalinski
Liebert Cassidy Whitmore

Catherine Kalinski
Pitcher Partners SA Pty Ltd

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory